Tasmania's business lobby backing Labor's budget savings measures, as Liberals launch state election campaign
Tasmania's peak business body has formally backed Labor's strategy to fix the state's budget, calling it a "courageous" plan just weeks out from a state election.
"For an opposition to put this sort of paper out three weeks before an election is fantastically courageous," Tasmanian Chamber of Commerce and Industry (TCCI) chief executive Michael Bailey said.
"What we're seeing from Dean Winter and Josh Willie is a plan to fix the Tasmanian budget problem that we face ourselves with at the moment."
"It's clear that the government need to react to this, we need to see from the Liberal Party their plan for budget repair."
Tasmanian Labor announced on Saturday its fiscal strategy which the party said would result in $1 billion in savings over the next four years and ensure all new revenue goes towards paying down debt.
It also included selling the state's share in the yet-to-be-built Marinus Link undersea power cable, and taking $100 million of revenue from the Motor Accidents Insurance Board.
Treasury has found the state is headed for $13 billion worth of debt by 2028.
"There are some tough decisions to be made and we understand that in business, we understand we need to be part of the discussion.
"We need to do better, especially in an economy like ours which is so small and so reliant on outside income the more we can really help developers move on their projects the better it'll be for all Tasmanians."
Labor Leader Dean Winter said, if elected, he would establish a budget repair round table made up of business, unions and the community sector.
"We know the size and scale of this problem is massive and it relies on people taking things seriously and accepting there's a problem," Mr Winter said.
Treasurer Guy Barnett has described Labor's budget plan as "one giant con".
"It includes sacking associate secretaries who don't exist, claiming savings from the Southern Outlet that will cease to exist after scrapping the jointly funded project, $171.5 million cuts in capital works, without saying where from, and a 10-point plan that is just a recycling of a number of policies already in existence," Mr Barnett said.
"Now, he's revealed his real plan is to sell government assets, with his reckless plan to give mainlanders control of our vital Marinus power connector."
The TCCI's endorsement of Labor's budget plans came as the Liberal Party officially launched its election campaign.
In a speech to the party faithful in Launceston on Sunday, Liberal Leader Jeremy Rockliff said Tasmania's economy was strong and the state wanted stability.
"We can deliver the services Tasmania needs because we have a strong economy; under a Liberal government our economy has grown 26 per cent over the course of the last ten years," he said.
"We now have an economy that's valued at over $40 billion."
"For our workers we've achieved the highest wage growth in the entire nation … we have a strong plan and it's working."
Mr Rockliff used the campaign launch to make the Liberals' most significant health announcement of the campaign so far — 250 new beds at the Launceston General Hospital (LGH).
He said construction would start on the northern health complex, a seven-storey, 25-bed tower in 2028.
He said the new building would "future-proof" hospital services in Tasmania's north.
"This means more single rooms, along with an expansion of cancer services.
"This will future-proof hospital services in the north and help to attract and retain those valued health professionals."
Labor's Health spokesperson Ella Haddad said the Liberals had promised the project before.
"Jeremy Rockliff's big election announcement is a project the Liberals promised five years and two early elections ago," Ms Haddad said.
"Tasmanians are sick of Liberal promises that never get delivered. It's time for change."
The tower is part of the Liberals' 10-year, $647.5 million redevelopment of the LGH.
Australian Nursing and Midwifery Federation acting Tasmanian branch secretary Phoebe Mansell said more beds were needed now.
"We welcome additional beds, but we've been saying for some time that the access and flow and hospital grid lock problems in the Launceston General Hospital emergency department need addressing … so what happens between now and then," she said.
Australian Medical Association Tasmanian president, Dr Michael Lumsden-Steel, said the project must be fit for purpose and allow for future growth.
"We know the Launceston General Hospital needs significant infrastructure builds … so 250 beds will be critical," he said.
"The key point here is when they go and build this new tower, it must be fit for purpose and it must also allow for projected demand … so we must get this right."
Tasmanians will head to the polls on Saturday July 19.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

ABC News
34 minutes ago
- ABC News
Queenslanders push for further measures to enable home ownership
A Sunshine Coast woman who works four casual jobs but still can not save enough money for a home deposit says a new shared equity scheme for first home-buyers fails to address the root cause of housing stress. The Boost to Buy Home Equity program announced in this year's Queensland state budget was designed to help 1,000 eligible first home-buyers enter the property market. The government said it would contribute 30 per cent equity for new builds and 25 per cent for existing homes, for properties up to the value of $1 million. It was designed to allow Queenslanders to purchase a home with a two per cent deposit. Buderim woman Jade Weatherill said the scheme would not help low-income households spending more than 30 per cent of their income on rent. She said the equity home buying schemes were only accessible to couples or higher-income earners. "Those schemes are great when it's a couple and they're both working full time and they might be lucky enough to have parents help them out with the deposit," she said. "But a single woman on casual employment … I'm not even going to bother trying." Ms Weatherill said flexible mortgage structures that allowed people to qualify for a loan regardless of their income and pay it off at a lower rate over time would be a better option. Ms Weatherill, who works as a face painter, writer, artist, disability support worker, teacher's assistant and in retail, said she still was not earning enough to guarantee housing security. "Any full-time proper job that I try and apply for there's thousands of people [also applying] and you hardly even hear back," she said. "So, I take the casual jobs hoping for something better one day." She said real estate agents constantly turned her applications away because she was a casual worker. "I don't apply for rentals anymore because I don't earn enough," she said. "There is nothing affordable." She said she rented privately but having no record of renting and no regulation could cause issues. "Landlords want cash because they don't want to claim it on tax," Ms Weatherill said. "You've got no security. "Stop making housing an investment for the rich. "It's a human right." Queensland's property market has never been more expensive. The latest Real Estate Institute of Queensland (REIQ) data shows the median sale price for Queensland houses grew 0.61 per cent across the first three months of the year to $812,000. Real Estate Institute of Queensland (REIQ) data from March showed million-dollar medians were maintained in Noosa ($1.34m), Brisbane ($1.215m), Gold Coast ($1.15m) and Sunshine Coast ($1.077m). REIQ chief executive Antonia Mercorella said the latest figures reflected an active market in early 2025 and highlighted an exponential five-year transformation with some regions doubling in value. "In March 2020, as Australia was shutting its borders and grappling with economic uncertainly, Queensland's annual median house price was just $490,000," she said. "Today it's $790,000, representing a staggering 61.22 per cent increase. "Queensland units have similarly surged from $385,000 to $640,000 — a 66.23 per cent increase in the median sales price over the same five-year period. "As prices have climbed, units have become a popular go-to option for buyers seeking more affordable entry points." Singles earning up to $150,000 and households with two adults earning up to $225,000 will be eligible for the new shared equity scheme. The $30,000 first home buyers grant that was due to expire at the end of the month has been extended to June 2026. But Anglicare Southern Queensland chief executive Sue Cooke said research showed the scheme did not go far enough for the state's most vulnerable. "We understand that Queensland's Boost to Buy Home Equity scheme will enable some Queenslanders to purchase a home with a two per cent deposit," she said. "There is still some way to go in assisting low-income households to achieve home ownership." Ms Cooke said research from the Queensland Council of Social Service (QCOSS) on living affordability revealed people on low incomes were unable to make meaningful savings. "Making a deposit as small as two per cent is unachievable for many Queenslanders," she said. "There is an opportunity for the government to assist with these cost-of-living pressures by reconsidering measures such as the $1,000 energy relief to ensure all Queenslanders can receive a fair go at achieving home ownership." Ms Cooke said mortgage guarantees and targeted shared equity arrangements, replacing stamp duty with universal land tax, and/or increasing the stamp duty threshold and land lease arrangements would make a more meaningful difference. "Whilst we welcome funding announcement for social housing to achieve the LNP's ambitious commitment to deliver over 2,000 homes in its first year; we are keen to understand specific detail of the Securing our Housing Foundations Plan, including how 52,000 people currently on the social housing waitlist will be supported," she said.

The Australian
an hour ago
- The Australian
StockTake: Star Minerals
Stockhead's Tylah Tully unpacks the latest from Star Minerals (ASX:SMS), as it endeavours to grow the gold resource at its Tumblegum South gold project. Star is testing for more high-grade lodes that could add to the resource and bolster the potential mine life. Watch the video to learn more. This video was developed in collaboration with Star Minerals, a Stockhead advertiser at the time of publishing. This video does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.

Daily Telegraph
an hour ago
- Daily Telegraph
LTR Pharma completes ED study milestone
Don't miss out on the headlines from Stockhead. Followed categories will be added to My News. LTR Pharma & co-development partner Aptar Pharma complete extractables study on SPONTAN All identified compounds below ICH safety thresholds for nasal spray-mist erectile dysfunction treatment Leachables study initiated to support FDA regulatory submission under real-world storage conditions Special Report: LTR Pharma has completed a key extractables study for its SPONTAN intranasal spray for erectile dysfunction and kicked off a leachables study as part of a regulatory development program. LTR Pharma (ASX:LTP) said the extractables study, conducted under the supervision of co-development partner Aptar Pharma, evaluated the bottle and pump components of SPONTAN's container closure system. The study confirmed that all detected compounds were below ICH safety thresholds – the internationally recognised standards adopted by the US Food and Drug Administration (FDA) and regulatory authorities worldwide for pharmaceutical impurities. LTR Pharma said the identified compounds would be monitored in the ongoing leachables study. FDA requires extractables and leachables (E&L) studies for all pharmaceutical products to ensure packaging materials do not compromise product safety or efficacy. For nasal spray products, these studies must meet specific regulatory thresholds due to direct tissue exposure. Leachables study now underway The leachables study has started under Aptar Pharma's management, evaluating the potential migration of the compounds from packaging into SPONTAN under real-world storage conditions. LTR Pharma said SPONTAN used industry-standard bottle and pump components as used in multiple FDA-approved nasal spray products. The study will run for at least 24 months to support shelf-life requirements. Consistent with FDA practice for nasal sprays, the company can submit its application once sufficient robust data is available, with study completion continuing post-approval as standard. E&L studies form part of LTR Pharma's comprehensive regulatory strategy following its FDA pre-IND meeting, where the FDA confirmed the proposed development pathway. The company said E&L data were required for the chemistry, manufacturing and controls (CMC) section of its planned new drug application (NDA). With extractables results meeting regulatory requirements, the company progresses to the leachables phase for comprehensive regulatory submission data. Watch: LTR's new appointment Progress on SPONTAN and new US-targeted ROXUS LTR Pharma continues to progress SPONTAN through established regulatory pathways while building commercial foundations through its Australian early access programs. It is also progressing its new ED nasal spray called ROXUS, which offers a fast-track pathway to serve patients through the US personalised healthcare sector. As with SPONTAN, ROXUS is based on the common active ingredient vardenafil. It will be delivered via the 503(a)-compounding pharmacy pathway, which exempts drugs from the usual approval, labelling and manufacturing requirements. "The completion of our extractables study and commencement of the leachables phase keep our regulatory program on schedule,' LTR Pharma executive chairman Lee Rodne said. 'Working with Aptar Pharma provides us with their established expertise in nasal spray device development and FDA submissions. 'These studies are necessary steps in our development pathway, and we look forward to progressing through each regulatory milestone." This article was developed in collaboration with LTR Pharma, a Stockhead advertiser at the time of publishing. This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions. Originally published as LTR Pharma completes study milestone for SPONTAN ED treatment